$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
When will sotoraxibu be available in China? _ Kanghule
2025-10-19 11:44:20
Check Details
Efficacy and effects of Mobocertinib
2025-10-19 11:44:20
Check Details
What are the precautions and contraindications of the new lung cancer drug Platinib?
2025-10-19 11:44:20
Check Details
Where can I buy the new lung cancer drug Platinib? _ Kanghule
2025-10-19 11:44:20
Check Details
Can genuine Mobotinib be purchased in the country? _ Kanghule
2025-10-19 11:44:20
Check Details
Where can I buy genuine larotrectinib in China?
2025-10-19 11:44:20
Check Details
How long will it take for the side effects of Capmatinib to appear? _ Kanghule
2025-10-19 11:44:20
Check Details
What are the applications and fields of capmatinib?
2025-10-19 11:44:20
Check Details
What are the purchase and medical insurance of Serpatinib?
2025-10-19 11:44:20
Check Details
What is the effect of dacomitinib on entering the brain and controlling bone metastasis?
2025-10-19 11:44:20
Check Details
Can dacomitinib be stopped if the rash is severe? What will happen if it is stopped?
2025-10-19 11:44:20
Check Details
Where can I buy genuine evantumumab in 2024?
2025-10-19 11:44:20
Check Details
1
2
...
4130
4131
4132
4133
4134
4135
4136
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Revolutionary Targeted Therapy for Hematological Malignancies
2
A New Option for Advanced Renal Cell Carcinoma Treatment
3
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
4
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
5
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
6
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Comprehensive Analysis of the Third-Generation EGFR-TKI
9
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
10
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
11
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
12
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient